重型自发性脑出血患者高血清半胱天冬酶-3水平与早期死亡相关
这项观察性前瞻性研究纳入6家西班牙医院的重型幕上自发性脑出血患者(GCS<9),排除动脉瘤、动静脉畸形及抗凝或纤溶治疗所致出血者,检测第1、4、8天血清半胱天冬酶-3水平,终点为30天死亡。死亡组(n=53)第1、4、8天血清半胱天冬酶-3水平均高于存活组(n=64,均p<0.001)。多因素logistic回归显示血清半胱天冬酶-3>0.167 ng/mL与30天死亡相关(OR=47.007,95%CI 4.838-456.727,p=0.001)。作者结论认为血清半胱天冬酶-3水平与重型幕上自发性脑出血不同部位患者的早期死亡相关,且出血后第一周内死亡组水平高于存活组。
要点
- 重型幕上自发性脑出血(GCS<9)患者中,死亡组(n=53)第1、4、8天血清半胱天冬酶-3水平均高于存活组(n=64),均p<0.001。
- 血清半胱天冬酶-3>0.167 ng/mL与30天死亡相关:OR=47.007(95%CI 4.838-456.727),p=0.001。
- 研究纳入6家西班牙医院,排除动脉瘤、动静脉畸形及抗凝或纤溶治疗所致脑出血患者。
- 作者结论认为血清半胱天冬酶-3水平与重型幕上自发性脑出血不同出血部位患者的早期死亡相关。
适用人群与场景
- 重型幕上自发性脑出血患者,定义为格拉斯哥昏迷评分<9,收治于6家西班牙医院。
- 排除动脉瘤、动静脉畸形所致脑出血患者,以及抗凝或纤溶治疗所致脑出血患者。
诊断标准与关键阈值
- 重型幕上自发性脑出血定义:格拉斯哥昏迷评分<9。
- 血清半胱天冬酶-3水平>0.167 ng/mL为多因素logistic回归中与30天死亡相关的阈值。
研究设计与关键结果
- 研究类型为观察性前瞻性研究,纳入6家西班牙医院的重型幕上自发性脑出血患者,死亡组n=53,存活组n=64。
- 死亡组第1天、第4天、第8天血清半胱天冬酶-3水平均高于存活组,均p<0.001。
- 多因素logistic回归显示血清半胱天冬酶-3>0.167 ng/mL与30天死亡相关:OR=47.007(95%CI 4.838-456.727),p=0.001。
- 研究终点为30天死亡。
证据类型、等级与局限
- 证据类型:观察性前瞻性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为血清半胱天冬酶-3水平与重型幕上自发性脑出血不同出血部位患者的早期死亡相关,且出血后第一周内死亡组水平高于存活组。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Apoptotic cell death leads to secondary brain injury after spontaneous intracerebral hemorrhage (SIH). There is an association between serum caspase-3 levels and late mortality (at 6 months) in patients with SIH in basal ganglia. The new objective of this study was to determine whether there exists an association between serum caspase-3 levels and early mortality (at 30 days) in patients with SIH at different sites and not only in basal ganglia.
METHODS: Patients with severe supratentorial SIH (defined as Glasgow Coma Scale < 9) admitted in 6 Spanish hospitals were included in this observational and prospective study. Patients with SIH due to aneurysm, arteriovenous malformation, and anticoagulant or fibrinolytic treatment were excluded. Serum caspase-3 levels at days 1, 4, and 8 of SIH were determined. Thirty-day mortality was the end-point study.
RESULTS: Non-surviving (n = 53) showed higher serum caspase-3 levels at days 1 (p < 0.001), 4 (p < 0.001), and 8 (p < 0.001) than survivor patients (n = 64). Multiple logistic regression analysis showed an association of serum caspase-3 levels > 0.167 ng/mL with 30-day mortality (Odds Ratio = 47.007; 95% CI = 4.838-456.727; p = 0.001).
CONCLUSIONS: The new findings of our study are that serum caspase-3 levels are associated with early mortality in patients with severe supratentorial SIH at different sites and that those levels during the first week of SIH are higher in non-survivors than in survivors.
参考来源
- Lorente L, Martín MM, Pérez-Cejas A, et al. High Serum Levels of Caspase-3 and Early Mortality in Patients with Severe Spontaneous Intracerebral Hemorrhage. Neurocrit Care. 2021. PMID: 32514709. doi:10.1007/s12028-020-01012-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。